Anika Therapeutics | ANIK - Eps Gewinn Pro Aktie

Aktienkurs
14.27
Täglich Wechseln
0.42 3.03%
Monatlich
31.52%
Jährlich
-7.88%
Q1 Prognose
13.43




Eps Veränderung Datum
Abbott USD 1.5 0.2 2025-12
Agenus USD -0.3 0.84 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Insmed USD -1.54 0.21 2025-12
Integra LifeSciences USD 0.83 0.29 2025-12
Intrexon USD -0.1 0.03 2024-06
J&J USD 2.46 0.34 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
MacroGenics USD -0.22 0.49 2025-12
Merit Medical Systems USD 1.04 0.12 2025-12
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.53 1.38 2025-12
Smith & Nephew USD 0.59 0.27 2025-12
Stryker USD 4.47 1.28 2025-12
Surmodics USD -0.25 0.28 2024-09
Veracyte USD 0.53 0.02 2025-12
Xencor USD -0.09 0.01 2025-12
Zimmer Biomet Holdings USD 2.42 0.52 2025-12